Financials

	2024	2025
Net sales	492K 433K 408K 372K 696K 47.23M 701K 4.9M 1.9M 24.04M 1.85M 1.81M 78.22M	89K 78.28K 73.8K 67.33K 126K 8.54M 127K 886K 343K 4.35M 334K 327K 14.15M
Net income	-1.04M -915K -862K -787K -1.47M -99.83M -1.48M -10.35M -4.01M -50.81M -3.9M -3.82M -165M	-3.98M -3.5M -3.3M -3.01M -5.63M -382M -5.67M -39.56M -15.33M -194M -14.93M -14.6M -632M
Net Debt	6.22M 5.47M 5.16M 4.7M 8.8M 597M 8.86M 61.86M 23.97M 304M 23.34M 22.84M 988M	911K 801K 755K 689K 1.29M 87.45M 1.3M 9.06M 3.51M 44.51M 3.42M 3.35M 145M

* Estimated data More financial data

Company Profile

DXI Capital Corp. is a Canada-based company. The Company has no active operations. It does not generate revenue from its operations. The Companyâ€™s wholly owned subsidiary is 0855524 B.C. Ltd.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
18/09/26	CA$0.2000	0.00%	1,200
17/09/26	CA$0.2000	0.00%	39,000
16/09/26	CA$0.2000	+5.26%	500

Delayed Quote Toronto S.E.

More quotes

Delayed Toronto S.E. 20:27:54 18/09/2026 +03			5-day change	1st Jan Change
0.2000 ^CAD	0.00%		0.00%	-33.33%

09-11	VVT Med Raises Total of $1.9 Million After Closing Second Tranche of Private Placement	MT
09-02	Vvt Med Inc. and Dermworks Enter Distribution and Evaluation Agreement for Sclerosafe in Portugal	CI

Market Cap	10.94M 9.62M 9.07M 8.27M 15.47M 1.05B 15.6M 109M 42.18M 534M 41.07M 40.18M 1.74B	P/E 2024 *	-	P/E 2025	-2.71x
Enterprise Value	11.85M 10.42M 9.83M 8.96M 16.76M 1.14B 16.89M 118M 45.69M 579M 44.49M 43.52M 1.88B	EV / Sales 2024 *	-	EV / Sales 2025	175x
Free-Float	-	Yield 2024 *	-	Yield 2025	-

09-11	VVT Med Raises Total of $1.9 Million After Closing Second Tranche of Private Placement	MT
09-02	Vvt Med Inc. and Dermworks Enter Distribution and Evaluation Agreement for Sclerosafe in Portugal	CI
08-31	VVT Med Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-30	VVT Med Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06-30	VVT Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
06-30	VVT Med Inc. Auditor Raises 'Going Concern' Doubt	CI
06-26	VVT Med Signs Exclusive Distribution Deal in Greece Worth About C$1.14 Million	MT
06-26	VVT Med Inc. Enters Exclusive Distribution Agreement With General Chemical Products S.A. For ScleroSafe Platform In Greece	CI
06-11	VVT Med Enters Dominican Republic Market	MT
06-11	VVT Med Inc. Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor	CI
05-26	VVT Med Announces First Patients Treated with VVT?s ScleroSafe System in Italy	CI
04-30	VVT Med Inc Announces Positive Clinical Data For ScleroSafe Catheter-Directed Sclerotherapy System	CI
04-27	VVT Med Signs "Largest" European Distribution Agreement to Date	MT

09-11	VVT Med Closes Second Tranche of Private Placement of Units; Over $1.8M in Total Proceeds Raised	AQ
09-02	VVT Med Advances Portugal Market Entry as Dermworks Begins ScleroSafe® Market Evaluation and Announces Corporate Updates	AQ
08-22	VVT Med Announces Debt Settlement and Equity Incentive Grants to Strengthen Capital Structure	AQ
06-26	VVT Med Expands European Commercial Footprint Through Exclusive Distribution Agreement in Greece	AQ
06-13	VVT Med Provides Update on Management Cease Trade Order	AQ

VVT Med Inc. Stock

Stocks

VVTM

CA91841T1084

Medical Equipment, Supplies & Distribution

Valuation: VVT Med Inc.

Chart: VVT Med Inc.

Latest news: VVT Med Inc.

Press Releases: VVT Med Inc.

News in other languages: VVT Med Inc.

Quotes and Performance

Price Extremes

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

11-26	VVT Medical Inc. (VVTM) ouvre les marchés
23/11/23	Sopra Steria Group: Willy il Coyote cerca di tenere il passo con Bip Bip
23/11/23	Sopra Steria Group: Coyote intenta seguir el ritmo de Bip Bip
23/11/23	Sopra Steria Group : le Coyote tente de suivre Bip Bip

Current month	+5.26%
1 month	-9.09%
3 months	-13.04%
6 months	-11.11%
Current year	-33.33%

1 month	0.15	0.24
Current year	0.15	0.45
1 year	0.15	0.45
3 years	0.15	0.56
5 years	0.15	0.56
10 years	0.15	0.56

Date	Insider	Type	Main position	% Market Cap.
4/28/26 A	Erez Tetro	Other	Chief Executive Officer	0%
4/27/26 A	Yair Aloni	Other	Chairman	0%
4/27/26 A	Yair Aloni	Other	Chairman	0%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VVT MED INC.	0.00%	0.00%	-48.72%	-	10.83M
ABBOTT LABORATORIES	-0.45%	-1.13%	-24.51%	+2.98%	175B
MEDTRONIC PLC	-1.05%	-4.59%	-7.55%	+10.27%	113B
CENCORA, INC.	-1.00%	+0.15%	+0.49%	+66.64%	59.13B
BECTON, DICKINSON AND COMPANY	-0.50%	-1.19%	-3.67%	-32.42%	48.82B
HOYA CORPORATION	+1.49%	+3.89%	+13.73%	+52.30%	48.69B
DEXCOM, INC.	-0.44%	-0.52%	+29.59%	-0.03%	33.01B
MEDLINE INC.	-0.14%	+7.91%	-	-	30.41B
WEST PHARMACEUTICAL SERVICES, INC.	-0.63%	+1.91%	+43.73%	+0.29%	26.29B
SARTORIUS STEDIM BIOTECH	-0.46%	+8.93%	+23.67%	-4.85%	23.87B
Average	-0.16%	+2.00%	+2.97%	+11.90%	55.83B
Weighted average by Cap.	-0.31%	-0.27%	-3.66%	+12.27%